CDH23 p.Pro240Leu
c.719C>T · rs121908354 · VCV4928
ClinGen expert panel — Hearing Loss VCEP
Pathogenic for nonsyndromic genetic deafness. Applied ACMG criteria (verbatim):
PP1_Strong PM2_Supporting PS4 PM3_Strong
Curation rationale (ClinGen, verbatim)
The allele frequency of the c.719C>T (p.Pro240Leu) variant in the CDH23 gene is 0.05% (10/17246) of East Asian chromosomes by gnomAD, which is a low enough frequency to apply PM2_Supporting based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss (PM2_Supporting). This variant has been reported in > 10 probands with hearing loss without evidence of retinal disease, including >5 homozygotes, at least 1 compound heterozygote with c.6712+1G>A variant, and >5 compound heterozygotes with rare variants of uncertain significance (PM3_Strong; PMID:24164807, 24618850, 25963016, 26264712, 17850630, 22899989). This variant has also segregated in 3 siblings with hearing loss (PP1_Strong, PMID: 17850630, 22899989). The variant was identified in the heterozygous state in a patient with Usher syndrome who also harbored a homozygous missense variant in MYO7A (PMID: 24618850). A case-control meta analysis found that the p.Pro240Leu variant was associated with a 12-fold higher risk of hearing loss compared to the wild-type allele (OR = 11.68; 95% CI = 3.16–43.24; PS4), though it should be noted that it appears that some probands were included in more than one study included in the meta-analysis (PMID 30367262). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PP1_Strong, PM3_Strong, PM2_Supporting, PS4.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7771 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.516 | indeterminate |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.96 | unconstrained · MANE · 359 kb · p 0.017 · regional, not allelic |
| Overall | ||
| CADD | 24.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CDH23
- Protein
- p.Pro240Leu
- Coding
- c.719C>T
- MANE Select
- NM_022124
- dbSNP
- rs121908354
- Type
- single nucleotide variant
- Location
- chr10:71570884 (GRCh38)
- Gene constraint
- LOEUF 0.685 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Residue 240
- the cadherin 3 domain; a UniProt-annotated variant site (in dfnb12)
Disease context
nonsyndromic genetic hearing loss — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Usher syndrome type 1Usher syndrome type 1Dautosomal recessive nonsyndromic hearing loss 12pituitary adenoma 5, multiple types
For Rare non-syndromic genetic deafness (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Infancy, Neonatal
Similar variants
- VSIR p.Ile240Thr Benign ★ same residue
- CDH23 p.Arg2029Trp Pathogenic ★★★ ⚠ same condition
- CDH23 p.Asp127Gly Likely pathogenic ★★★ same condition
- CDH23 p.Glu956Lys Pathogenic ★★★ same condition
- CDH23 c.1515-12G>A Uncertain significance ★★★ same condition
- CDH23 p.Ala3190Val Uncertain significance ★★★ ⚠ same condition
- CDH23 p.Arg301Gln Uncertain significance ★★★ same condition
- CDH23 p.Arg3189Gln Uncertain significance ★★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdh23-p-pro240leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown